ClinicalTrials.govpublic full text
Botulinum Toxin Type A (Botox) in the Management of Levodopa-Induced Peak-Dose Dyskinesias in Parkinson's Disease
parkinson disease, parkinson's disease, levodopa-induced cervical dyskinesias, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 805992
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.